Datasets for Antimicrobial Sales Reduction Potential in the Context of the European Green Deal

Two indicators were used to assess the contribution of EU Member States: (1) sales of antimicrobials (AMs) in 2022 (mg/PCU) and the rate of change (%) in sales of AMs over the progress period (2018-2022); (2) a result indicator from the CAP National Strategic Plans (SP) for 2023–2027 – R.43 “Limiting antimicrobial use”. This indicator means limiting AMs use and is calculated as a share of livestock units concerned by supported actions to limit the use of AMs (prevention/reduction). The region examined by the research covers 27 EU Member States: Austria (AT), Belgium (BE), Bulgaria (BG), Croatia (HR), Czech Republic (CZ), Cyprus (CY), Denmark (DK), Estonia (EE), Finland (FI), France (FR), Germany (DE), Greece (EL), Hungary (HU), Ireland (IE), Italy (IT), Latvia (LV), Lithuania (LT), Luxembourg (LU), Malta (MT), Netherlands (NL), Poland (PL), Portugal (PT), Romania (RO), Slovakia (SK), Slovenia (SI), Spain (ES) and Sweden (SE). In the case of Belgium, there are two CAP SPs for the regions of Wallonia and Flanders; therefore, the forecast indicators were analysed for each region.